Jefferies analyst Michael Yee reiterated a Buy rating and $230.00 price target on Amgen (NASDAQ: AMGN) after pre-clinical data for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE